Nevirapine Cristers

Nevirapine, the active ingredient in Nevirapine Cristers, is a non‑nucleoside reverse transcriptase inhibitor presented as an oral tablet for oral use. It is employed in the management of HIV‑1 infection in adults and adolescents, typically as part of combination antiretroviral therapy.

GNH USA supplies Nevirapine Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Nevirapine is an NNRTI used in antiretroviral regimens targeting HIV‑1 replication.

- HIV‑1 infection (treatment‑naïve adults): reduces plasma viral load when combined with other antiretrovirals. - HIV‑1 infection (treatment‑naïve adolescents ≥12 years): improves immune recovery and suppresses viral replication. - HIV‑1 infection (prevention of mother‑to‑child transmission): used in selected pregnant women as part of combination therapy.

Nevirapine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Rash - Nausea - Fatigue - Headache - Abdominal pain - Dizziness

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe hepatic failure or hepatitis - Hypersensitivity reactions (including fever and eosinophilia) - Grade 3/4 neutropenia - Anaphylaxis - Severe skin reactions requiring hospitalization

When prescribing Nevirapine, clinicians should observe several safety considerations.

- Baseline liver function: assess hepatic enzymes before initiating therapy. - Monitor for rash: discontinue promptly if severe skin reactions develop. - Hepatitis B/C co‑infection: use with caution and monitor liver status. - Pregnancy: evaluate risk‑benefit; avoid initiation in women with CD4 >250 cells/µL. - Drug resistance: avoid use after virologic failure on other NNRTIs. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Nevirapine interacts with several medicines, influencing its plasma concentration or toxicity.

Major Interactions (Avoid): - Rifampicin - St. John’s wort - Protease inhibitors boosted with ritonavir - Certain azole antifungals (e.g., ketoconazole) - Carbamazepine

Moderate Interactions (Monitor Closely): - Efavirenz - Zidovudine - Lamivudine - Hormonal contraceptives - Warfarin